Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

por Buzatto, I.P.C., Ribeiro-Silva, A., Andrade, J.M., Carrara, H.H.A., Silveira, W.A., Tiezzi, D.G.
Publicado 2017

1747P Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: Patterns in a Brazilian Univer...

por Pimentel, F.F., Borba, J.M.C., Rodrigues, T.C.G.F., Peruchi, K.P.I., Carrara, H.H.A., de Andrade, J.M., Candido dos Reis, F.J.
Publicado 2020

Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil

por Magário, M.B., dos Santos, R.R., Teixeira, L.A., Tiezzi, D.G., Pimentel, F.F., Carrara, H.H.A., de Andrade, J.M., dos Reis, F.J. Candido
Publicado 2022